Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND6 pseudogene 13 (MTND6P13) is classified as a mitochondrial pseudogene derived from the MT-ND6 gene, which encodes a core subunit of NADH:ubiquinone oxidoreductase (Complex I) in the mitochondrial electron transport chain. The pseudogene does not encode a functional protein, is not part of respiratory chain complex assembly, and has no evidence supporting significant biological or disease-related roles. This distinguishes it from the functional MT-ND6 gene, which is vital for oxidative phosphorylation and is associated with mitochondrial diseases when mutated[2][5][1][4][6]. If you are seeking information on the functional Complex I subunit gene (MT-ND6), distinct and detailed structured information is available, but MTND6P13 itself is not a canonical or experimentally supported protein target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MTND6 pseudogene 13, mitochondrially encoded NADH:ubiquinone oxidorereductase core subunit 6 pseudogene 13 (MTND6P13).